Cytokinetics, Incorporated annual free cash flow for fiscal 2025 was -$535 million, a decrease of 33.8% from -$400 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | ($535M) | ($400M) | ($416M) | ($311M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Free Cash Flow | ($151M) | ($148M) | ($117M) | ($132M) | ($137M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CYTK metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All CYTK financial statements → Interactive CYTK charts →
About TickerBase · Data methodology & sources